Markers of oxidant stress that are clinically relevant in aging and age-related disease

Mechanisms of Ageing and Development

Volumn 134, Issue 3-4, 2013, Pages 139-157

  Jacob, Kimberly D ^a   Noren Hooten, Nicole ^a   Trzeciak, Andrzej R ^b   Evans, Michele K ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

CRP; DNA oxidation; Protein oxidation; RNA oxidation; Single strand breaks

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 HYDROXYGUANINE; BIOLOGICAL MARKER; CATALASE; DNA; GLUTATHIONE; ISOPROSTANE DERIVATIVE; PEROXIDASE; PROTEIN; RNA; SUPEROXIDE DISMUTASE;

AGE DISTRIBUTION; AGING; ALZHEIMER DISEASE; ARTHRITIS; ARTICLE; BASAL CELL CARCINOMA; BREAST CANCER; CELL RESPIRATION; CELL SURVIVAL; COHORT ANALYSIS; COMET ASSAY; DNA OXIDATION; DOUBLE STRANDED DNA BREAK; ESSENTIAL HYPERTENSION; ESTERIFICATION; FLUORESCENCE ACTIVATED CELL SORTING; GROWTH, DEVELOPMENT AND AGING DISORDERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; IMMUNOCYTOCHEMISTRY; INFLAMMATION; LIPID OXIDATION; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MACROMOLECULE; MEDICAL LITERATURE; MUTAGENESIS; NEWCASTLE DISEASE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN OXIDATION; RACE DIFFERENCE; RNA OXIDATION; SIGNAL TRANSDUCTION; SINGLE STRANDED DNA BREAK; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

AGE FACTORS; AGING; ANIMALS; BIOLOGICAL MARKERS; DEOXYGUANOSINE; DNA BREAKS, DOUBLE-STRANDED; ERYTHROCYTES; FREE RADICALS; GLUTATHIONE; GUANINE; HEME; HUMANS; INFLAMMATION; ISOPROSTANES; LIPID PEROXIDATION; OXIDANTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84875082255     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2013.02.008     Document Type: Article

References (275)

1. Abe T., Tohgi H., Isobe C., Murata T., Sato C. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. Journal of Neuroscience Research 2002, 70:447-450.
2. Abe T., Isobe C., Murata T., Sato C., Tohgi H. Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease. Neuroscience Letters 2003, 336:105-108.
3. Alam Z.I., Jenner A., Daniel S.E., Lees A.J., Cairns N., Marsden C.D., Jenner P., Halliwell B. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. Journal of Neurochemistry 1997, 69:1196-1203.
4. Alam Z.I., Halliwell B., Jenner P. No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease. Journal of Neurochemistry 2000, 75:840-846.
5. Ame J.-C., Fouquerel E., Gauthier L.R., Biard D., Boussin F.D., Dantzer F., de Murcia G., Schreiber V. Radiation-induced mitotic catastrophe in PARG-deficient cells. Journal of Cell Science 2009, 122:1990-2002.
6. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:7915-7922.
7. Andreoli R., Manini P., Palma G.D., Alinovi R., Goldoni M., Niessen W.M.A., Mutti A. Quantitative determination of urinary 8-oxo-7,8-dihydro-2''-deoxyguanosine, 8-oxo-7,8-dihydroguanine, 8-oxo-7,8-dihydroguanosine, and their non-oxidized forms: daily concentration profile in healthy volunteers. Biomarkers 2010, 15:221-231.
8. Andreoli R., Mutti A., Goldoni M., Manini P., Apostoli P., De Palma G. Reference ranges of urinary biomarkers of oxidized guanine in (2'-deoxy)ribonucleotides and nucleic acids. Free Radical Biology and Medicine 2011, 50:254-261.
9. Aviram M. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radical Research 2000, 33(Suppl.):S85-S97.
10. Bachi A., Zuccato E., Baraldi M., Fanelli R., Chiabrando C. Measurement of urinary 8-Epi-prostaglandin F2alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers. Free Radical Biology and Medicine 1996, 20:619-624.
11. Bandeen Roche K., Walston J., Huang Y., Semba R., Ferrucci L. Measuring systemic inflammatory regulation in older adults: evidence and utility. Rejuvenation Research 2009, 12:403-410.
12. Barciszewski J., Barciszewska M.Z., Siboska G., Rattan S.I., Clark B.F. Some unusual nucleic acid bases are products of hydroxyl radical oxidation of DNA and RNA. Molecular Biology Reports 1999, 26:231-238.
13. Barnett Y.A., King C.M. An investigation of antioxidant status, DNA repair capacity and mutation as a function of age in humans. Mutation Research 1995, 338:115-128.
14. Barzilay J.I., Blaum C., Moore T., Xue Q.L., Hirsch C.H., Walson J., Fried L.P. Insulin resistance and inflammation as precursors of frailty: the cardiovascular health study. Archives of Internal Medicine 2007, 167:635-641.
15. Basu S., Whiteman M., Mattey D.L., Halliwell B. Raised levels of F2-isoprostanes and prostaglandin F2α in different rheumatic diseases. Annals of the Rheumatic Diseases 2001, 60:627-631.
16. Beal M.F. Oxidatively modified proteins in aging and disease. Free Radical Biology and Medicine 2002, 32:797-803.
17. Bellacosa A., Moss E.G. RNA repair: damage control. Current Biology 2003, 13:R482-R484.
18. Beutler E., Gelbart T. Plasma glutathione in health and in patients with malignant disease. Journal of Laboratory and Clinical Medicine 1985, 105:581-584.
19. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigo R., Gingeras T.R., Margulies E.H., Weng Z., Snyder M., Dermitzakis E.T., Thurman R.E., Kuehn M.S., Taylor C.M., Neph S., Koch C.M., Asthana S., Malhotra A., Adzhubei I., Greenbaum J.A., Andrews R.M., Flicek P., Boyle P.J., Cao H., Carter N.P., Clelland G.K., Davis S., Day N., Dhami P., Dillon S.C., Dorschner M.O., Fiegler H., Giresi P.G., Goldy J., Hawrylycz M., Haydock A., Humbert R., James K.D., Johnson B.E., Johnson E.M., Frum T.T., Rosenzweig E.R., Karnani N., Lee K., Lefebvre G.C., Navas P.A., Neri F., Parker S.C., Sabo P.J., Sandstrom R., Shafer A., Vetrie D., Weaver M., Wilcox S., Yu M., Collins F.S., Dekker J., Lieb J.D., Tullius T.D., Crawford G.E., Sunyaev S., Noble W.S., Dunham I., Denoeud F., Reymond A., Kapranov P., Rozowsky J., Zheng D., Castelo R., Frankish A., Harrow J., Ghosh S., Sandelin A., Hofacker I.L., Baertsch R., Keefe D., Dike S., Cheng J., Hirsch H.A., Sekinger E.A., Lagarde J., Abril J.F., Shahab A., Flamm C., Fried C., Hackermuller J., Hertel J., Lindemeyer M., Missal K., Tanzer A., Washietl S., Korbel J., Emanuelsson O., Pedersen J.S., Holroyd N., Taylor R., Swarbreck D., Matthews N., Dickson M.C., Thomas D.J., Weirauch M.T., Gilbert J., Drenkow J., Bell I., Zhao X., Srinivasan K.G., Sung W.K., Ooi H.S., Chiu K.P., Foissac S., Alioto T., Brent M., Pachter L., Tress M.L., Valencia A., Choo S.W., Choo C.Y., Ucla C., Manzano C., Wyss C., Cheung E., Clark T.G., Brown J.B., Ganesh M., Patel S., Tammana H., Chrast J., Henrichsen C.N., Kai C., Kawai J., Nagalakshmi U., Wu J., Lian Z., Lian J., Newburger P., Zhang X., Bickel P., Mattick J.S., Carninci P., Hayashizaki Y., Weissman S., Hubbard T., Myers R.M., Rogers J., Stadler P.F., Lowe T.M., Wei C.L., Ruan Y., Struhl K., Gerstein M., Antonarakis S.E., Fu Y., Green E.D., Karaoz U., Siepel A., Taylor J., Liefer L.A., Wetterstrand K.A., Good P.J., Feingold E.A., Guyer M.S., Cooper G.M., Asimenos G., Dewey C.N., Hou M., Nikolaev S., Montoya-Burgos J.I., Loytynoja A., Whelan S., Pardi F., Massingham T., Huang H., Zhang N.R., Holmes I., Mullikin J.C., Ureta-Vidal A., Paten B., Seringhaus M., Church D., Rosenbloom K., Kent W.J., Stone E.A., Batzoglou S., Goldman N., Hardison R.C., Haussler D., Miller W., Sidow A., Trinklein N.D., Zhang Z.D., Barrera L., Stuart R., King D.C., Ameur A., Enroth S., Bieda M.C., Kim J., Bhinge A.A., Jiang N., Liu J., Yao F., Vega V.B., Lee C.W., Ng P., Yang A., Moqtaderi Z., Zhu Z., Xu X., Squazzo S., Oberley M.J., Inman D., Singer M.A., Richmond T.A., Munn K.J., Rada-Iglesias A., Wallerman O., Komorowski J., Fowler J.C., Couttet P., Bruce A.W., Dovey O.M., Ellis P.D., Langford C.F., Nix D.A., Euskirchen G., Hartman S., Urban A.E., Kraus P., Van Calcar S., Heintzman N., Kim T.H., Wang K., Qu C., Hon G., Luna R., Glass C.K., Rosenfeld M.G., Aldred S.F., Cooper S.J., Halees A., Lin J.M., Shulha H.P., Xu M., Haidar J.N., Yu Y., Iyer V.R., Green R.D., Wadelius C., Farnham P.J., Ren B., Harte R.A., Hinrichs A.S., Trumbower H., Clawson H., Hillman-Jackson J., Zweig A.S., Smith K., Thakkapallayil A., Barber G., Kuhn R.M., Karolchik D., Armengol L., Bird C.P., de Bakker P.I., Kern A.D., Lopez-Bigas N., Martin J.D., Stranger B.E., Woodroffe A., Davydov E., Dimas A., Eyras E., Hallgrimsdottir I.B., Huppert J., Zody M.C., Abecasis G.R., Estivill X., Bouffard G.G., Guan X., Hansen N.F., Idol J.R., Maduro V.V., Maskeri B., McDowell J.C., Park M., Thomas P.J., Young A.C., Blakesley R.W., Muzny D.M., Sodergren E., Wheeler D.A., Worley K.C., Jiang H., Weinstock G.M., Gibbs R.A., Graves T., Fulton R., Mardis E.R., Wilson R.K., Clamp M., Cuff J., Gnerre S., Jaffe D.B., Chang J.L., Lindblad-Toh K., Lander E.S., Koriabine M., Nefedov M., Osoegawa K., Yoshinaga Y., Zhu B., de Jong P.J. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816.
20. Bjelland S., Seeberg E. Mutagenicity, toxicity and repair of DNA base damage induced by oxidation. Mutation Research 2003, 531:37-80.
21. Blasiak J., Trzeciak A., Malecka-Panas E., Drzewoski J., Wojewodzka M. In vitro genotoxicity of ethanol and acetaldehyde in human lymphocytes and the gastrointestinal tract mucosa cells. Toxicol In Vitro 2000, 14:287-295.
22. Boiteux S., Gajewski E., Laval J., Dizdaroglu M. Substrate specificity of the Escherichia coli Fpg protein (formamidopyrimidine-DNA glycosylase): excision of purine lesions in DNA produced by ionizing radiation or photosensitization. Biochemistry 1992, 31:106-110.
23. Bolukbas C., Bolukbas F.F., Kocyigit A., Aslan M., Selek S., Bitiren M., Ulukanligil M. Relationship between levels of DNA damage in lymphocytes and histopathological severity of chronic hepatitis C and various clinical forms of hepatitis B. Journal of Gastroenterology and Hepatology 2006, 21:610-616.
24. Bonnefont-Rousselot D., Lacomblez L., Jaudon M., Lepage S., Salachas F., Bensimon G., Bizard C., Doppler V., Delattre J., Meininger V. Blood oxidative stress in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 2000, 178:57-62.
25. Broedbaek K., Poulsen H.E., Weimann A., Kom G.D., Schwedhelm E., Nielsen P., Boger R.H. Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis. Free Radical Biology and Medicine 2009, 47:1230-1233.
26. Broedbaek K., Ribel-Madsen R., Henriksen T., Weimann A., Petersen M., Andersen J.T., Afzal S., Hjelvang B., Roberts L.J., Vaag A., Poulsen P., Poulsen H.E. Genetic and environmental influences on oxidative damage assessed in elderly Danish twins. Free Radical Biology and Medicine 2011, 50:1488-1491.
27. Broedbaek K., Siersma V., Andersen J.T., Petersen M., Afzal S., Hjelvang B., Weimann A., Semba R.D., Ferrucci L., Poulsen H.E. The association between low-grade inflammation, iron status and nucleic acid oxidation in the elderly. Free Radical Research 2011, 45:409-416.
28. Butterfield D.A. Oxidative stress in neurodegenerative disorders. Antioxidants and Redox Signaling 2006, 8:1971-1973.
29. Cecchi C., Latorraca S., Sorbi S., Iantomasi T., Favilli F., Vincenzini M.T., Liguri G. Gluthatione level is altered in lymphoblasts from patients with familial Alzheimer's disease. Neuroscience Letters 1999, 275:152-154.
30. Chapple I.L. Reactive oxygen species and antioxidants in inflammatory diseases. Journal of Clinical Periodontology 1997, 24:287-296.
31. Chevion M., Berenshtein E., Stadtman E.R. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radical Research 2000, 33(Suppl.):S99-S108.
32. Christen Y. Oxidative stress and Alzheimer disease. The American Journal of Clinical Nutrition 2000, 71:621s-629s.
33. Clyne B., Olshaker J.S. The C-reactive protein. Journal of Emergency Medicine 1999, 17:1019-1025.
34. Collerton J., Martin-Ruiz C., Davies K., Hilkens C.M., Isaacs J., Kolenda C., Parker C., Dunn M., Catt M., Jagger C., von Zglinicki T., Kirkwood T.B.L. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ study. Mechanisms of Ageing and Development 2012, 133:456-466.
35. Collins A.R. The Comet Assay 2002, 163-177.
36. Collins A.R., Duthie S.J., Dobson V.L. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis 1993, 14:1733-1735.
37. Collins A.R., Dobson V.L., Dusinska M., Kennedy G., Stetina R. The comet assay: what can it really tell us?. Mutation Research 1997, 375:183-193.
38. Collins A.R., Gedik C.M., Olmedilla B., Southon S., Bellizzi M. Oxidative DNA damage measured in human lymphocytes: large differences between sexes and between countries, and correlations with heart disease mortality rates. FASEB Journal 1998, 12:1397-1400.
39. Collins A.R., Raslova K., Somorovska M., Petrovska H., Ondrusova A., Vohnout B., Fabry R., Dusinska M. DNA damage in diabetes: correlation with a clinical marker. Free Radical Biology & Medicine 1998, 25:373-377.
40. Collins A.R., Cadet J., Moller L., Poulsen H.E., Vina J. Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells?. Archives of Biochemistry and Biophysics 2004, 423:57-65.
41. Collins A.R., Oscoz A.A., Brunborg G., Gaivã£o I., Giovannelli L., Kruszewski M., Smith C.C., atAtina R. The comet assay: topical issues. Mutagenesis 2008, 23:143-151.
42. Conrad C.C., Marshall P.L., Talent J.M., Malakowsky C.A., Choi J., Gracy R.W. Oxidized proteins in Alzheimer's plasma. Biochemical and Biophysical Research Communications 2000, 275:678-681.
43. Cooke M.S. A commentary on Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG'. What is ELISA detecting?. Free Radical Biology and Medicine 2009, 47:30-31.
44. Cooke M.S., Evans M.D., Dizdaroglu M., Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB Journal 2003, 17:1195-1214.
45. Cooke M.S., Olinski R., Loft S. Measurement and meaning of oxidatively modified DNA lesions in urine. Cancer Epidemiology Biomarkers & Prevention 2008, 17:3-14.
46. Cooke M.S., Barregard L., Mistry V., Potdar N., Rozalski R., Gackowski D., Siomek A., Foksinski M., Svoboda P., Kasai H., Konje J.C., Sallsten G., Evans M.D., Olinski R. Interlaboratory comparison of methodologies for the measurement of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine. Biomarkers 2009, 14:103-110.
47. Cookson M.R., Shaw P.J. Oxidative stress and motor neurone disease. Brain Pathology 1999, 9:165-186.
48. Costa A.D., Pierre S.V., Cohen M.V., Downey J.M., Garlid K.D. cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovascular Research 2008, 77:344-352.
49. Cracowski J.-L., Durand T. Cardiovascular pharmacology and physiology of the isoprostanes. Fundamental & Clinical Pharmacology 2006, 20:417-427.
50. Cracowski J.L., Marpeau C., Carpentier P.H., Imbert B., Hunt M., Stanke-Labesque F., Bessard G. Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders. Arthritis & Rheumatism 2001, 44:1143-1148.
51. Cracowski J.L., Durand T., Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends in Pharmacological Sciences 2002, 23:360-366.
52. Crankshaw D. Effects of the isoprostane, 8-epi-prostaglandin F2 alpha, on the contractility of the human myometrium in vitro. European Journal of Pharmacology 1995, 285:151-158.
53. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A. Biomarkers of oxidative damage in human disease. Clinical Chemistry 2006, 52:601-623.
54. Dar M.E., Jorgensen T.J. Deletions at short direct repeats and base substitutions are characteristic mutations for bleomycin-induced double- and single-strand breaks, respectively, in a human shuttle vector system. Nucleic Acids Research 1995, 23:3224-3230.
55. Dav G., Falco A., Patrono C. Lipid peroxidation in diabetes mellitus. Antioxidants & Redox Signalling 2005, 7:256-268.
56. Davies S.S., Roberts Ii L.J. F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radical Biology and Medicine 2011, 50:559-566.
57. De Flora S., Izzotti A., Walsh D., Degan P., Petrilli G.L., Lewtas J. Molecular epidemiology of atherosclerosis. The FASEB Journal 1997, 11:1021-1031.
58. De Luca G., Russo M.T., Degan P., Tiveron C., Zijno A., Meccia E., Ventura I., Mattei E., Nakabeppu Y., Crescenzi M., Pepponi R., Pèzzola A., Popoli P., Bignami M. A role for oxidized DNA precursors in Huntington's disease-like striatal neurodegeneration. PLoS Genetics 2008, 4:e1000266.
59. Demirbag R., Yilmaz R., Gur M., Kocyigit A., Celik H., Guzel S., Selek S. Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome. Mutation Research 2005, 578:298-307.
60. Demirbag R., Yilmaz R., Gur M., Celik H., Guzel S., Selek S., Kocyigit A. DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Inernationalt Journal of Clinical Practice 2006, 60:1187-1193.
61. Diem E., Ivancsits S., Rudiger H.W. Basal levels of DNA strand breaks in human leukocytes determined by comet assay. Journal of Toxicology and Environmental Health, Part A 2002, 65:641-648.
62. Ding Q., Markesbery W.R., Chen Q., Li F., Keller J.N. Ribosome dysfunction is an early event in Alzheimer's disease. The Journal of Neuroscience 2005, 25:9171-9175.
63. Domenici F.A., Vannucchi M.T., Jordao A.A., Meirelles M.S., Vannucchi H. DNA oxidative damage in patients with dialysis treatment. Renal Failure 2005, 27:689-694.
64. Dominguez C., Ruiz E., Gussinye M., Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care 1998, 21:1736-1742.
65. Dusinska M., Dzupinkova Z., Wsolova L., Harrington V., Collins A.R. Possible involvement of XPA in repair of oxidative DNA damage deduced from analysis of damage, repair and genotype in a human population study. Mutagenesis 2006, 21:205-211.
66. Dworski R., Murray J.J., Roberts L.J., Oates J.A., Morrow J.D., Fisher L., Sheller J.R. Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress. American Journal of Respiratory and Critical Care Medicine 1999, 160:1947-1951.
67. Erden-İnal M., Sunal E., Kanbak G. Age-related changes in the glutathione redox system. Cell Biochemistry and Function 2002, 20:61-66.
68. Evans M.D., Olinski R., Loft S., Cooke M.S. Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a noninvasive biomarker of oxidative stress. The FASEB Journal 2010, 24:1249-1260.
69. Fasshauer M., Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003, 46:1594-1603.
70. Feairheller D.L., Park J.Y., Sturgeon K.M., Williamson S.T., Diaz K.M., Veerabhadrappa P., Brown M.D. Racial differences in oxidative stress and inflammation: in vitro and in vivo. Clinical and Translational Science 2011, 4:32-37.
71. Fialkow L., Wang Y., Downey G.P. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radical Biology and Medicine 2007, 42:153-164.
72. Floor E., Wetzel M.G. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. Journal of Neurochemistry 1998, 70:268-275.
73. Floyd R.A., Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiology of Aging 2002, 23:795-807.
74. Fried L.P., Xue Q.-L., Cappola A.R., Ferrucci L., Chaves P., Varadhan R., Guralnik J.M., Leng S.X., Semba R.D., Walston J.D., Blaum C.S., Bandeen-Roche K. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2009, 64A:1049-1057.
75. Gabbita S.P., Lovell M.A., Markesbery W.R. Increased Nuclear DNA oxidation in the brain in Alzheimer's disease. Journal of Neurochemistry 1998, 71:2034-2040.
76. Gambhir J.K., Lali P., Jain A.K. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clinical Biochemistry 1997, 30:351-355.
77. Garm C., Moreno-Villanueva M., Bürkle A., Petersen I., Bohr V.A., Christensen K., Stevnsner T. Age and gender effects on DNA strand break repair in peripheral blood mononuclear cells. Aging Cell 2012, 12:58-66.
78. Garrison W.M., Jayko M.E., Bennett W. Radiation-induced oxidation of protein in aqueous solution. Radiation Research 1962, 16:483-502.
79. Gedik C.M., Collins A. Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB Journal 2005, 19:82-84.
80. Gianni P., Jan K.J., Douglas M.J., Stuart P.M., Tarnopolsky M.A. Oxidative stress and the mitochondrial theory of aging in human skeletal muscle. Experimental Gerontology 2004, 39:1391-1400.
81. Gil L., Siems W., Mazurek B., Gross J., Schroeder P., Voss P., Grune T. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radical Research 2006, 40:495-505.
82. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19:257-267.
83. Gopaul N.K., Anggard E.E., Mallet A.I., Betteridge D.J., Wolff S.P., Nourooz-Zadeh J. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Letters 1995, 368:225-229.
84. Gopaul N.K., Halliwell B., Anggrd E.E. Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet. Free Radical Research 2000, 33:115-127.
85. Griffiths H.R. Antioxidants and protein oxidation. Free Radical Research 2000, 33(Suppl.):S47-S58.
86. Grune T., Shringarpure R., Sitte N., Davies K. Age-related changes in protein oxidation and proteolysis in mammalian cells. The Journal of Gerontology, Series A: Biological Sciences and Medical Sciences 2001, 56:B459-B467.
87. Guentchev M., Siedlak S.L., Jarius C., Tagliavini F., Castellani R.J., Perry G., Smith M.A., Budka H. Oxidative damage to nucleic acids in human prion disease. Neurobiology of Disease 2002, 9:275-281.
88. Gur M., Yildiz A., Demirbag R., Yilmaz R., Kocyigit A., Celik H., Aksoy N. Increased lymphocyte deoxyribonucleic acid damage in patients with cardiac syndrome X. Mutation Research 2007, 617:8-15.
89. Hadi Yasa M., Kacmaz M., Serda Ozturk H., Durak I. Antioxidant status of erythrocytes from patients with cirrhosis. Hepato-Gastroenterology 1999, 46:2460-2463.
90. Haghdoost S., Maruyama Y., Pecoits-Filho R., Heimburger O., Seeberger A., Anderstam B., Suliman M.E., Czene S., Lindholm B., Stenvinkel P., Harms-Ringdahl M. Elevated serum 8-oxo-dG in hemodialysis patients: a marker of systemic inflammation?. Antioxidantrs and Redox Signaling 2006, 8:2169-2173.
91. Hager K., Machein U., Krieger S., Platt D., Seefried G., Bauer J. Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiology of Aging 1994, 15:771-772.
92. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. Lancet 1994, 344:721-724.
93. Halliwell B. Oxidative stress and neurodegeneration: where are we now. Journal of Neurochemistry 2006, 97:1634-1658.
94. Hampel H., Sunderland T., Kötter H.U., Schneider C., Teipel S.J., Padberg F., Dukoff R., Levy J., Möller H.-J. Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease. Brain Research 1998, 780:356-359.
95. Hannon-Fletcher M.P., O'Kane M.J., Moles K.W., Weatherup C., Barnett C.R., Barnett Y.A. Levels of peripheral blood cell DNA damage in insulin dependent diabetes mellitus human subjects. Mutation Research 2000, 460:53-60.
96. Harman D. Aging: a theory based on free radical and radiation chemistry. Journal of Gerontology 1956, 11:298-300.
97. Hayashi M., Araki S., Kohyama J., Shioda K., Fukatsu R. Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome. Brain Development 2005, 27:34-38.
98. Henriksen T., Hillestrom P.R., Poulsen H.E., Weimann A. Automated method for the direct analysis of 8-oxo-guanosine and 8-oxo-2'-deoxyguanosine in human urine using ultraperformance liquid chromatography and tandem mass spectrometry. Free Radical Biology and Medicine 2009, 47:629-635.
99. Hitchon C., El-Gabalawy H. Oxidation in rheumatoid arthritis. Arthritis Research and Therapy 2004, 6:265-278.
100. Hoelzl C., Knasmüller S., Misík M., Collins A., Dusinská M., Nersesyan A. Use of single cell gel electrophoresis assays for the detection of DNA-protective effects of dietary factors in humans: recent results and trends. Mutation Research/Reviews in Mutation Research 2009, 681:68-79.
101. Hofer T., Badouard C., Bajak E., Ravanat J.L., Mattsson A., Cotgreave I.A. Hydrogen peroxide causes greater oxidation in cellular RNA than in DNA. Biological Chemistry 2005, 386:333-337.
102. Hofer T., Seo A.Y., Prudencio M., Leeuwenburgh C. A method to determine RNA and DNA oxidation simultaneously by HPLC-ECD: greater RNA than DNA oxidation in rat liver after doxorubicin administration. Biological Chemistry 2006, 387:103-111.
103. Hold G.L., El-Omar E.M. Genetic aspects of inflammation and cancer. Biochemical Journal 2008, 410:225-235.
104. Holt S., Reeder B., Wilson M., Harvey S., Morrow J.D., Roberts L.J., Moore K. Genetic aspects of inflammation and cancer. Biochemical Journal 1999, 353:1241.
105. Honda K., Smith M.A., Zhu X., Baus D., Merrick W.C., Tartakoff A.M., Hattier T., Harris P.L., Siedlak S.L., Fujioka H., Liu Q., Moreira P.I., Miller F.P., Nunomura A., Shimohama S., Perry G. Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. The Journal of Biological Chemistry 2005, 280:20978-20986.
106. Howard C., Ferrucci L., Sun K., Fried L.P., Walston J., Varadhan R., Guralnik J.M., Semba R.D. Oxidative protein damage is associated with poor grip strength among older women living in the community. Journal of Applied Physiology 2007, 103:17-20.
107. Huang L.C., Clarkin K.C., Wahl G.M. Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:4827-4832.
108. Hubbard R.E., O'Mahony M.S., Savva G.M., Calver B.L., Woodhouse K.W. Inflammation and frailty measures in older people. Journal of Cellular and Molecular Medicine 2009, 13:3103-3109.
109. Humphreys V., Martin R.M., Ratcliffe B., Duthie S., Wood S., Gunnell D., Collins A.R. Age-related increases in DNA repair and antioxidant protection: a comparison of the Boyd Orr Cohort of elderly subjects with a younger population sample. Age and Ageing 2007, 36:521-526.
110. Hussain S.P., Schwank J., Staib F., Wang X.W., Harris C.C. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 2007, 26:2166-2176.
111. Hyland P., Duggan O., Turbitt J., Coulter J., Wikby A., Johansson B., Tompa A., Barnett C., Barnett Y. Nonagenarians from the Swedish NONA Immune Study have increased plasma antioxidant capacity and similar levels of DNA damage in peripheral blood mononuclear cells compared to younger control subjects. Experimental Gerontology 2002, 37:465-473.
112. Isobe C., Abe T., Terayama Y. Homocysteine may contribute to pathogenesis of RNA damage in brains with Alzheimer's disease. Neurodegenerative Diseases 2009, 6:252-257.
113. Ivashkevich A., Redon C.E., Nakamura A.J., Martin R.F., Martin O.A. Use of the gamma-H2AX assay to monitor DNA damage and repair in translational cancer research. Cancer Letters 2012, 327:123-133.
114. Janssen L.J. Isoprostanes and Lung Vascular Pathology. American Journal of Respiratory Cell and Molecular Biology 2008, 39:383-389.
115. Janssen L.J., Premji M., Netherton S., Catalli A., Cox G., Keshavjee S., Crankshaw D.J. Excitatory and inhibitory actions of isoprostanes in human and canine airway smooth muscle. Journal of Pharmacology and Experimental Therapeutics 2000, 295:506-511.
116. Johnson P.A., Clements P., Hudson K., Caldecott K.W. The mitotic spindle and DNA damage-induced apoptosis. Toxicology Letters 2000, 112-113:59-67.
117. Jones D.P. Redefining oxidative stress. Antioxidants and Redox Signaling 2006, 8:1865-1879.
118. Kadiiska M.B., Gladen B.C., Baird D.D., Germolec D., Graham L.B., Parker C.E., Nyska A., Wachsman J.T., Ames B.N., Basu S., Brot N., Fitzgerald G.A., Floyd R.A., George M., Heinecke J.W., Hatch G.E., Hensley K., Lawson J.A., Marnett L.J., Morrow J.D., Murray D.M., Plastaras J., Roberts L.J., Rokach J., Shigenaga M.K., Sohal R.S., Sun J., Tice R.R., Van Thiel D.H., Wellner D., Walter P.B., Tomer K.B., Mason R.P., Barrett J.C. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?. Free Radical Biology & Medicine 2005, 38:698-710.
119. Kasapoglu M., Ozben T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Experimental Gerontology 2001, 36:209-220.
120. Kedziora-Kornatowska K., Czuczejko J., Pawluk H., Kornatowski T., Motyl J., Szadujkis-Szadurski L., Szewczyk-Golec K., Kedziora J. The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension. Cellular & Molecular Biology Letters 2004, 9:635-641.
121. Kedziora-Kornatowska K., Szewczyk-Golec K., Czuczejko J., Lumen K.v.M.d.Pawluk H., Motyl J., Karasek M., Kedziora J. Effect of melatonin on the oxidative stress in erythrocytes of healthy young and elderly subjects. Journal of Pineal Research 2007, 42:153-158.
122. Kikuchi A., Takeda A., Onodera H., Kimpara T., Hisanaga K., Sato N., Nunomura A., Castellani R.J., Perry G., Smith M.A., Itoyama Y. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiology of Disease 2002, 9:244-248.
123. King C.M., Bristow-Craig H.E., Gillespie E.S., Barnett Y.A. In vivo antioxidant status DNA damage, mutation and DNA repair capacity in cultured lymphocytes from healthy 75- to 80-year-old humans. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1997, 377:137-147.
124. Knaapen A.M., Schins R.P., Polat D., Becker A., Borm P.J. Mechanisms of neutrophil-induced DNA damage in respiratory tract epithelial cells. Molecular and Cellular Biochemistry 2002, 234-235:143-151.
125. Kondo M., Oya-Ito T., Kumagai T., Osawa T., Uchida K. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. The Journal of Biological Chemistry 2001, 276:12076-12083.
126. Kopjar N., Garaj-Vrhovac V. Application of the alkaline comet assay in human biomonitoring for genotoxicity: a study on Croatian medical personnel handling antineoplastic drugs. Mutagenesis 2001, 16:71-78.
127. Kopjar N., Zeljezic D., Garaj-Vrhovac V. Evaluation of DNA damage in white blood cells of healthy human volunteers using the alkaline comet assay and the chromosome aberration test. Acta Biochimica Polonica 2006, 53:321-336.
128. Korolainen M.A., Goldsteins G., Alafuzoff I., Koistinaho J., Pirttila T. Proteomic analysis of protein oxidation in Alzheimer's disease brain. Electrophoresis 2002, 23:3428-3433.
129. Kosower N.S., Kosower E.M. The glutathione status of cells. International Review of Cytology 1978, 54:109-160.
130. Kruszewski M., Wojewodzka M., Iwanenko T., Collins A.R., Szumiel I. Application of the comet assay for monitoring DNA damage in workers exposed to chronic low-dose irradiation II. Base damage. Mutation Research 1998, 416:37-57.
131. Lang C.A., Naryshkin S., Schneider D.L., Mills B.J., Lindeman R.D. Low blood glutathione levels in healthy aging adults. Journal of Laboratory and Clinical Medicine 1992, 120:720-725.
132. Lee J.W., Beebe K., Nangle L.A., Jang J., Longo-Guess C.M., Cook S.A., Davisson M.T., Sundberg J.P., Schimmel P., Ackerman S.L. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 2006, 443:50-55.
133. Leng S., Chaves P., Koenig K., Walston J. Serum Interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. Journal of the American Geriatrics Society 2002, 50:1268-1271.
134. Leng S., Cappola A., Andersen R., Blackman M., Koenig K., Blair M., Walston J. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clinical and Experimental Research 2004, 16:153-157.
135. Leng S., Yang H., Walston J. Decreased cell proliferation and altered cytokine production in frail older adults. Aging Clinical and Experimental Research 2004, 16:249-252.
136. Leng S.X., Xue Q.-L., Tian J., Walston J.D., Fried L.P. Inflammation and frailty in older women. Journal of the American Geriatrics Society 2007, 55:864-871.
137. Leng S.X., Tian X., Matteini A., Li H., Hughes J., Jain A., Walston J.D., Fedarko N.S. IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults. Age and Ageing 2011, 40:475-481.
138. Levine R.L., Stadtman E.R. Oxidative modification of proteins during aging. Experimental Gerontology 2001, 36:1495-1502.
139. Libby P., Ridker P.M. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. American Journal of Medicine 2004, 116(Suppl. 6A):9S-16S.
140. Lih-Brody L., Powell S.R., Collier K.P., Reddy G.M., Cerchia R., Kahn E., Weissman G.S., Katz S., Floyd R.A., McKinley M.J., Fisher S.E., Mullin G.E. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Digestive Diseases and Sciences 1996, 41:2078-2086.
141. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993, 362:709-715.
142. Liu H., Harrell L.E., Shenvi S., Hagen T., Liu R.M. Gender differences in glutathione metabolism in Alzheimer's disease. Journal of Neuroscience Research 2005, 79:861-867.
143. Lou M.F., Dickerson J.E. Protein-thiol mixed disulfides in human lens. Experimental Eye Research 1992, 55:889-896.
144. Lovell M.A., Gabbita S.P., Markesbery W.R. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. Journal of Neurochemistry 1999, 72:771-776.
145. Lyras L., Cairns N.J., Jenner A., Jenner P., Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. Journal of Neurochemistry 1997, 68:2061-2069.
146. Maeda H., Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Moscow) 1998, 63:854-865.
147. Malek A., Sager R., Schneider H. Effect of hypoxia, oxidative stress and lipopolysaccharides on the release of prostaglandins and cytokines from
148. Malins D.C., Johnson P.M., Wheeler T.M., Barker E.A., Polissar N.L., Vinson M.A. Age-related radical-induced DNA damage is linked to prostate cancer. Cancer Research 2001, 61:6025-6028.
149. Manini P., De Palma G., Andreoli R., Marczynski B., Hanova M., Mozzoni P., Naccarati A., Vodickova L., Hlavac P., Mutti A., Vodicka P. Biomarkers of nucleic acid oxidation, polymorphism in, and expression of, hOGG1 gene in styrene-exposed workers. Toxicology Letters 2009, 190:41-47.
150. Mantle D., Falkous G., Walker D. Quantification of protease activities in synovial fluid from rheumatoid and osteoarthritis cases: comparison with antioxidant and free radical damage markers. Clinica Chimica Acta 1999, 284:45-58.
151. Marcon F., Andreoli C., Rossi S., Verdina A., Galati R., Crebelli R. Assessment of individual sensitivity to ionizing radiation and DNA repair efficiency in a healthy population. Mutation Research - Genetic Toxicology and Environmental Mutagenesis 2003, 541:1-8.
152. Martinet W., Knaapen M.W.M., De Meyer G.R.Y., Herman A.G., Kockx M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002, 106:927-932.
153. Martinet W., de Meyer G.R., Herman A.G., Kockx M.M. Reactive oxygen species induce RNA damage in human atherosclerosis. European Journal of Clinical Investigation 2004, 34:323-327.
154. März P., Heese K., Hock C., Golombowski S., Müller-Spahn F., Rose-John S., Otten U. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients. Neuroscience Letters 1997, 239:29-32.
155. Mastaloudis A., Morrow J.D., Hopkins D.W., Devaraj S., Traber M.G. Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners. Free Radical Biology and Medicine 2004, 36:1329-1341.
156. Mastaloudis A., Yu T.-W., O'Donnell R.P., Frei B., Dashwood R.H., Traber M.G. Endurance exercise results in DNA damage as detected by the comet assay. Free Radical Biology and Medicine 2004, 36:966-975.
157. Mateos R., Bravo L. Chromatographic and electrophoretic methods for the analysis of biomarkers of oxidative damage to macromolecules (DNA, lipids, and proteins). Journal of Separation Science 2007, 30:175-191.
158. Matsubara L.S., Machado P.E. Age-related changes of glutathione content, glutathione reductase and glutathione peroxidase activity of human erythrocytes. Brazilian Journal of Medical and Biological research 1991, 24:449-454.
159. McCarty M.F. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Medical Hypotheses 1999, 52:465-477.
160. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Annals of Neurology 1994, 36:747-751.
161. Mecocci P., Fanó G., Fulle S., MacGarvey U., Shinobu L., Polidori M.C., Cherubini A., Vecchiet J., Senin U., Beal M.F. Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. Free Radical Biology and Medicine 1999, 26:303-308.
162. Meister A., Anderson M.E. Glutathione. Annual Review of Biochemistry 1983, 52:711-760.
163. Miller S.B. Prostaglandins in health and disease: an overview. Seminars in Arthritis and Rheumatism 2006, 36:37-49.
164. Moller P. Assessment of reference values for DNA damage detected by the comet assay in human blood cell DNA. Mutation Research 2006, 612:84-104.
165. Montine T.J., Beal M.F., Robertson D., Cudkowicz M.E., Biaggioni I., O'Donnell H., Zackert W.E., Roberts L.J., Morrow J.D. Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease. Neurology 1999, 52:1104-1105.
166. Montine T.J., Neely M.D., Quinn J.F., Beal M.F., Markesbery W.R., Roberts L.J., Morrow J.D. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radical Biology and Medicine 2002, 33:620-626.
167. Montine T., Peskind E., Quinn J., Wilson A., Montine K., Galasko D. Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers. NeuroMolecular Medicine 2011, 13:37-43.
168. Montuschi P., Corradi M., Ciabattoni G., Nightingale J., Kharitonov S.A., Barnes P.J. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. American Journal of Respiratory and Critical Care Medicine 1999, 160:216-220.
169. Montuschi P., Barnes P., Roberts L.J. Insights into oxidative stress: the isoprostanes. Current Medicinal Chemistry 2007, 14:703-717.
170. Moore K.P., Holt S.G., Patel R.P., Svistunenko D.A., Zackert W., Goodier D., Reeder B.J., Clozel M., Anand R., Cooper C.E., Morrow J.D., Wilson M.T., Darley-Usmar V., Roberts L.J. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. The Journal of Biological Chemistry 1998, 273:31731-31737.
171. Morocz M., Kalman J., Juhasz A., Sinko I., McGlynn A.P., Downes C.S., Janka Z., Rasko I. Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer's disease. Neurobiology of Aging 2002, 23:47-53.
172. Morris A.A., Zhao L., Patel R.S., Jones D.P., Ahmed Y., Stoyanova N., Gibbons G.H., Vaccarino V., Din-Dzietham R., Quyyumi A.A. Differences in systemic oxidative stress based on race and the metabolic syndrome: the Morehouse and Emory Team up to Eliminate Health Disparities (META-Health) study. Metabolic Syndrome and Related Disorders 2012, 10:252-259.
173. Morrow J.D., Roberts L.J. The isoprostanes: unique bioactive products of lipid peroxidation. Progress in Lipid Research 1997, 36:1-21.
174. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:9383-9387.
175. Morrow J.D., Frei B., Longmire A.W., Gaziano J.M., Lynch S.M., Shyr Y., Strauss W.E., Oates J.A., Roberts L.J. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. The New England Journal of Medicine 1995, 332:1198-1203.
176. Muller W.U., Bauch T., Stüben G., Sack H., Streffer C. Radiation sensitivity of lymphocytes from healthy individuals and cancer patients as measured by the comet assay. Radiation and Environmental Biophysics 2001, 40:83-89.
177. Muller W.U., Bauch T., Streffer C., Von Mallek D. Does radiotherapy affect the outcome of the comet assay?. British Journal of Radiology 2002, 75:608-614.
178. Mutlu-Turkoglu U., Ilhan E., Oztezcan S., Kuru A., Aykac-Toker G., Uysal M. Age-related increases in plasma malondialdehyde and protein carbonyl levels and lymphocyte DNA damage in elderly subjects. Clinical Biochemistry 2003, 36:397-400.
179. Nagababu E., Rifkind J.M. Formation of fluorescent heme degradation products during the oxidation of hemoglobin by hydrogen peroxide. Biochemical and Biophysical Research Communications 1998, 247:592-596.
180. Nagababu E., Rifkind J.M. Heme degradation by reactive oxygen species. Antioxidants and Redox Signaling 2004, 6:967-978.
181. Nagababu E., Mohanty J.G., Bhamidipaty S., Ostera G.R., Rifkind J.M. Role of the membrane in the formation of heme degradation products in red blood cells. Life Sciences 2010, 86:133-138.
182. Nakabeppu Y., Tsuchimoto D., Yamaguchi H., Sakumi K. Oxidative damage in nucleic acids and Parkinson's disease. Journal of Neuroscience Research 2007, 85:919-934.
183. Nakamura A.J., Chiang Y.J., Hathcock K.S., Horikawa I., Sedelnikova O.A., Hodes R.J., Bonner W.M. Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence. Epigenetics Chromatin 2008, 1:6.
184. Noren Hooten N., Ejiogu N., Zonderman A.B., Evans M.K. Association of oxidative DNA damage and C-reactive protein in women at risk for cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2012, 32:2776-2784.
185. Nunomura A., Perry G., Hirai K., Aliev G., Takeda A., Chiba S., Smith M.A. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome. Annals of the New York Academy of Sciences 1999, 893:362-364.
186. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., Smith M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. Journal of Neuroscience 1999, 19:1959-1964.
187. Nunomura A., Perry G., Pappolla M.A., Friedland R.P., Hirai K., Chiba S., Smith M.A. Neuronal oxidative stress precedes amyloid-beta deposition in Down Syndrome. Journal of Neuropathology and Experimental Neurology 2000, 59:1011-1017.
188. Nunomura A., Chiba S., Kosaka K., Takeda A., Castellani R.J., Smith M.A., Perry G. Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies. NeuroReport 2002, 13:2035-2039.
189. Nunomura A., Castellani R., Zhu X., Moreira P., Perry G., Smith M. Involvement of oxidative stress in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2006, 65:631-641.
190. Nunomura A., Tamaoki T., Tanaka K., Motohashi N., Nakamura M., Hayashi T., Yamaguchi H., Shimohama S., Lee H.G., Zhu X., Smith M.A., Perry G. Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease. Neurobiology of Disease 2010, 37:731-737.
191. Oguogho A., Kaliman J., Sinzinger H. Levels of eicosanoids (6-oxo-PGF1 alpha and 8-epi-PGF2 alpha) in human and porcine lymphatics and lymph. Lymphology 1998, 31:186-189.
192. Oliver C.N., Ahn B.W., Moerman E.J., Goldstein S., Stadtman E.R. Age-related changes in oxidized proteins. Journal of Biological Chemistry 1987, 262:5488-5491.
193. Pagano G., Zatterale A., Degan P., d'Ischia M., Kelly F., Pallardó F., Kodama S. Multiple involvement of oxidative stress in Werner syndrome phenotype. Biogerontology 2005, 6:233-243.
194. Park E.M., Shigenaga M.K., Degan P., Korn T.S., Kitzler J.W., Wehr C.M., Kolachana P., Ames B.N. Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:3375-3379.
195. Parthasarathy S., Litvinov D., Selvarajan K., Garelnabi M. Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability. Biochimica et Biophysica Acta 2008, 1781:221-231.
196. Paz-Elizur T., Elinger D., Leitner-Dagan Y., Blumenstein S., Krupsky M., Berrebi A., Schechtman E., Livneh Z. Development of an enzymatic DNA repair assay for molecular epidemiology studies: Distribution of OGG activity in healthy individuals. DNA Repair 2007, 6:45-60.
197. Perry G., Nunomura A., Hirai K., Zhu X., Perez M., Avila J., Castellani R.J., Atwood C.S., Aliev G., Sayre L.M., Takeda A., Smith M.A. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?. Free Radical Biology and Medicine 2002, 33:1475-1479.
198. Petersen R.B., Siedlak S.L., Lee H.G., Kim Y.S., Nunomura A., Tagliavini F., Ghetti B., Cras P., Moreira P.I., Castellani R.J., Guentchev M., Budka H., Ironside J.W., Gambetti P., Smith M.A., Perry G. Redox metals and oxidative abnormalities in human prion diseases. Acta Neuropathology 2005, 110:232-238.
199. Pilch D.R., Sedelnikova O.A., Redon C., Celeste A., Nussenzweig A., Bonner W.M. Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. Biochemistry and Cell Biology 2003, 81:123-129.
200. Piperakis S.M., Visvardis E.E., Sagnou M., Tassiou A.M. Effects of smoking and aging on oxidative DNA damage of human lymphocytes. Carcinogenesis 1998, 19:695-698.
201. Pirmohamed M., Williams D., Tingle M.D., Barry M., Khoo S.H., O'Mahony C., Wilkins E.G., Breckenridge A.M., Park B.K. Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency. AIDS 1996, 10:501-507.
202. Popanda O., Ebbeler R., Twardella D., Helmbold I., Gotzes F., Schmezer P., Thielmann H.W., von Fournier D., Haase W., Sautter-Bihl M.L., Wenz F., Bartsch H., Chang-Claude J. Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. International Journal of Radiation Oncology, Biology, Physics 2003, 55:1216-1225.
203. Pratico D., Barry O.P., Lawson J.A., Adiyaman M., Hwang S.W., Khanapure S.P., Iuliano L., Rokach J., FitzGerald G.A. IPF2alpha-I: an index of lipid peroxidation in humans. Proceedings of the National Academy f Sciencesof the United States of America 1998, 95:3449-3454.
204. Pratico D., Iuliano L., Basili S., Ferro D., Camastra C., Cordova C., FitzGerald G.A., Violi F. Enhanced lipid peroxidation in hepatic cirrhosis. Journal of Investigative Medicine 1998, 46:51-57.
205. Pratico D., Clark C.M., Liun F., Rokach J., Lee V.Y., Trojanowski J.Q. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Archives of Neurology 2002, 59:972-976.
206. Pryor W.A., Stanley J.P., Blair E. Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides. Lipids 1976, 11:370-379.
207. Rahman I., MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. European Respiratory Journal 2000, 16:534-554.
208. Rajaee-Behbahani N., Schmezer P., Risch A., Rittgen W., Kayser K.W., Dienemann H., Schulz V., Drings P., Thiel S., Bartsch H. Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer. International Journal of Cancer 2001, 95:86-91.
209. Rajeswari N., Ahuja Y.R., Malini U., Chandrashekar S., Balakrishna N., Rao K.V., Khar A. Risk assessment in first degree female relatives of breast cancer patients using the alkaline Comet assay. Carcinogenesis 2000, 21:557-561.
210. Ramírez R., Carracedo J., Soriano S., Jiménez R., Martín-Malo A., Rodríguez M., Blasco M., Aljama P. Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. American Journal of Kidney Diseases 2005, 45:353-359.
211. Range S.P., Dunster C., Knox A.J., Kelly F.J. Treatment of pulmonary exacerbations of cystic fibrosis leads to improved antioxidant status. European Respiratory Journal 1999, 13:560-564.
212. Reilly M., Delanty N., Lawson J.A., FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996, 94:19-25.
213. Reiner A.P., Aragaki A.K., Gray S.L., Wactawski-Wende J., Cauley J.A., Cochrane B.B., Kooperberg C.L., Woods N.F., LaCroix A.Z. Inflammation and thrombosis biomarkers and incident frailty in postmenopausal women. The American Journal of Medicine 2009, 122:947-954.
214. Rhee Y., Valentine M.R., Termini J. Oxidative base damage in RNA detected by reverse transcriptase. Nucleic Acids Research 1995, 23:3275-3282.
215. Rifkind J., Augo O., Levy A., Monticone R. Formation of free radicals under hypoxia. Surviving Hypoxia: Mechanisms of Control and Adaptation 1993, CRC Press, Boca Raton, FL, USA. P.W. Hochachka, P.L. Lutz, T. Sick, M. Rosenthal, G. van den Thillart (Eds.).
216. Rifkind J.M., Ramasamy S., Manoharan P.T., Nagababu E., Mohanty J.G. Redox reactions of hemoglobin. Antioxidants and Redox Signaling 2004, 6:657-666.
217. Rizvi S.I., Maurya P.K. Markers of Oxidative Stress in Erythrocytes during Aging in Humans. Annals of the New York Academy of Sciences 2007, 1100:373-382.
218. Roberts L.J., Morrow J.D. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radical Biology and Medicine 2000, 28:505-513.
219. Rodin S.N., Rodin A.S. Origins and selection of p53 mutations in lung carcinogenesis. Seminars in Cancer Biology 2005, 15:103-112.
220. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. The Journal of Biological Chemistry 1998, 273:5858-5868.
221. Rogakou E.P., Boon C., Redon C., Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. The Journal of Cell Biology 1999, 146:905-916.
222. Rokach J., Khanapure S.P., Hwang S.W., Adiyaman M., Lawson J.A., FitzGerald G.A. Nomenclature of isoprostanes: a proposal. Prostaglandins 1997, 54:853-873.
223. Roubenoff R., Harris T.B., Abad L.W., Wilson P.W., Dallal G.E., Dinarello C.A. Monocyte cytokine production in an elderly population: effect of age and inflammation. Journal of Gerontology Series A Biological Sciences Medical Sciences 1998, 53:M20-26.
224. Ryan K.A., Smith M.F., Sanders M.K., Ernst P.B. Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression. Infection and Immunity 2004, 72:2123-2130.
225. Samiec P.S., Drews-Botsch C., Flagg E.W., Kurtz J.C., Sternberg P., Reed R.L., Jones D.P. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radical Biology and Medicine 1998, 24:699-704.
226. Schmaltz H.N., Fried L.P., Xue Q.-L., Walston J., Leng S.X., Semba R.D. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. Journal of the American Geriatrics Society 2005, 53:747-754.
227. Schmid T.E., Eskenazi B., Baumgartner A., Marchetti F., Young S., Weldon R., Anderson D., Wyrobek A.J. The effects of male age on sperm DNA damage in healthy non-smokers. Human Reproduction 2007, 22:180-187.
228. Schurman S.H., Dunn C.A., Greaves R., Yu B., Ferrucci L., Croteau D.L., Seidman M.M., Bohr V.A. Age-related disease association of endogenous gamma-H2AX Foci in mononuclear cells derived from leukapheresis. PLoS One 2012, 7:e45728.
229. Sedelnikova O.A., Rogakou E.P., Panyutin I.G., Bonner W.M. Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiation Reserach 2002, 158:486-492.
230. Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metabolism Reviews 2000, 32:307-326.
231. Shan X., Lin C.L. Quantification of oxidized RNAs in Alzheimer's disease. Neurobiology of Aging 2006, 27:657-662.
232. Shen Z., Wu W., Hazen S.L. Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. Biochemistry 2000, 39:5474-5482.
233. Shan X., Tashiro H., Lin C.L. The identification and characterization of oxidized RNAs in Alzheimer's disease. Journal of Neuroscience 2003, 23:4913-4921.
234. Sies H. Oxidative stress: oxidants and antioxidants. Experimental Physiology 1997, 82:291-295.
235. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research 1988, 175:184-191.
236. Singh N.P., Muller C.H., Berger R.E. Effects of age on DNA double-strand breaks and apoptosis in human sperm. Fertility and Sterility 2003, 80:1420-1430.
237. Sinzinger H., Oguogho A., Kaliman J. Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphatics. Lymphology 1997, 30:155-159.
238. Siomek A., Gackowski D., Rozalski R., Dziaman T., Szpila A., Guz J., Olinski R. Higher leukocyte 8-oxo-7,8-dihydro-2'-deoxyguanosine and lower plasma ascorbate in aging humans?. Antioxidants & Redox Signaling 2007, 9:143-150.
239. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:10540-10543.
240. Smith T.R., Miller M.S., Lohman K.K., Case L.D., Hu J.J. DNA damage and breast cancer risk. Carcinogenesis 2003, 24:883-889.
241. Smith C.C., O'Donovan M.R., Martin E.A. hOGG1 recognizes oxidative damage using the comet assay with greater specificity than FPG or ENDOIII. Mutagenesis 2006, 21:185-190.
242. Spitz M.R., Wei Q., Dong Q., Amos C.I., Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiology Biomarkers and Prevention 2003, 12:689-698.
243. Stadtman E.R. Role of oxidized amino acids in protein breakdown and stability. Methods in Enzymology 1995, 258:379-393.
244. Stadtman E.R. Protein oxidation in aging and age-related diseases. Annals of the New York Academy of Sciences of the United States of America 2001, 928:22-38.
245. Stadtman E.R., Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Chemical Research in Toxicology 1997, 10:485-494.
246. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiological Reviews 2004, 84:1381-1478.
247. Stoyanova E., Sandoval S.B., Zúñiga L.A., El-Yamani N., Coll E., Pastor S., Reyes J., Andrés E., Ballarin J., Xamena N., Marcos R. Oxidative DNA damage in chronic renal failure patients. Nephrology dialysis transplantation 2010, 25:879-885.
248. Szaflik J.P., Janik-Papis K., Synowiec E., Ksiazek D., Zaras M., Wozniak K., Szaflik J., Blasiak J. DNA damage and repair in age-related macular degeneration. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2009, 669:169-176.
249. Szanton S.L., Rifkind J.M., Mohanty J.G., Miller E.R., Thorpe R.J., Nagababu E., Epel E.S., Zonderman A.B., Evans M.K. Racial discrimination is associated with a measure of red blood cell oxidative stress: a potential pathway for racial health disparities. International Journal of Behavioral Medicine 2012, 19:489-498.
250. Takai H., Smogorzewska A., de Lange T. DNA damage foci at dysfunctional telomeres. Current Biology 2003, 13:1549-1556.
251. Tanaka M., Chock P.B., Stadtman E.R. Oxidized messenger RNA induces translation errors. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:66-71.
252. Tanaka M., Han S., Kupfer P.A., Leumann C.J., Sonntag W.E. An assay for RNA oxidation induced abasic sites using the Aldehyde Reactive Probe. Free Radical Research 2011, 45:237-247.
253. Tateyama M., Takeda A., Onodera Y., Matsuzaki M., Hasegawa T., Nunomura A., Hirai K., Perry G., Smith M.A., Itoyama Y. Oxidative stress and predominant Abeta42(43) deposition in myopathies with rimmed vacuoles. Acta Neuropathology 2003, 105:581-585.
254. Te Koppele J.M., Lucassen P.J., Sakkee A.N., Van Asten J.G., Ravid R., Swaab D.F., Van Bezooijen C.F. 8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease. Neurobiology of Aging 1996, 17:819-826.
255. Telci A., Cakatay U., Salman S., Satman I., Sivas A. Oxidative protein damage in early stage Type 1 diabetic patients. Diabetes Research and Clinical Practice 2000, 50:213-223.
256. Thompson D., Pepys M.B., Wood S.P. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 1999, 7:169-177.
257. Traverso N., Patriarca S., Balbis E., Furfaro A.L., Cottalasso D., Pronzato M.A., Carlier P., Botta F., Marinari U.M., Fontana L. Anti malondialdehyde-adduct immunological response as a possible marker of successful aging. Experimental Gerontology 2003, 38:1129-1135.
258. Trzeciak A., Kowalik J., Malecka-Panas E., Drzewoski J., Wojewodzka M., Iwanenko T., Blasiak J. Genotoxicity of chromium in human gastric mucosa cells and peripheral blood lymphocytes evaluated by the single cell gel electrophoresis (comet assay). Medical Science Monitor 2000, 6:24-29.
259. Trzeciak A.R., Barnes J., Ejiogu N., Foster K., Brant L.J., Zonderman A.B., Evans M.K. Age, sex, and race influence single-strand break repair capacity in a human population. Free Radical Biology and Medicine 2008, 45:1631-1641.
260. Trzeciak A.R., Barnes J., Evans M.K. A modified alkaline comet assay for measuring DNA repair capacity in human populations. Radiation Research 2009, 169:110-121.
261. Trzeciak A.R., Mohanty J.G., Jacob K.D., Barnes J., Ejiogu N., Lohani A., Zonderman A.B., Rifkind J.M., Evans M.K. Oxidative damage to DNA and single strand break repair capacity: Relationship to other measures of oxidative stress in a population cohort. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2012, 736:93-103.
262. van Leeuwen F.W., de Kleijn D.P., van den Hurk H.H., Neubauer A., Sonnemans M.A., Sluijs J.A., Koycu S., Ramdjielal R.D., Salehi A., Martens G.J., Grosveld F.G., Peter J., Burbach H., Hol E.M. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 1998, 279:242-247.
263. Voss P., Siems W. Clinical oxidation parameters of aging. Free Radical Research 2006, 40:1339-1349.
264. Walston J., McBurnie M., Newman A., Tracy R.P., Kop W.J., Hirsch C.H., Gottdiener J.S., Fried L.P. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: Results from the cardiovascular health study. Archives of Internal Medicine 2002, 162:2333-2341.
265. Wang J., Xiong S., Xie C., Markesbery W.R., Lovell M.A. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. Journal of Neurochemistry 2005, 93:953-962.
266. Watters J.L., Satia J.A., Kupper L.L. Correlates of antioxidant nutrients and oxidative DNA damage differ by race in a cross-sectional study of healthy African American and white adults. Nutrition Research 2008, 28:565-576.
267. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M.A., Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:1614-1618.
268. Wei Q., Cheng L., Amos C.I., Wang L.E., Guo Z., Hong W.K., Spitz M.R. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. Journal of the National Cancer Institute 2000, 92:1764-1772.
269. Weimann A., Belling D., Poulsen H.E. Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography-electrospray tandem mass spectrometry. Nucleic Acids Research 2002, 30:e7.
270. Wojewodzka M., Kruszewski M., Iwanenko T., Collins A.R., Szumiel I. Application of the comet assay for monitoring DNA damage in workers exposed to chronic low-dose irradiation. I. Strand breakage. Mutation Research 1998, 416:21-35.
271. Wood-Kaczmar A., Gandhi S., Wood N.W. Understanding the molecular causes of Parkinson's disease. Trends in Molecular Medicine 2006, 12:521-528.
272. Wu I.C., Shiesh S.-C., Kuo P.-H., Lin X.-Z. High oxidative stress is correlated with frailty in elderly Chinese. Journal of the American Geriatrics Society 2009, 57:1666-1671.
273. Yan T., Berry S.E., Desai A.B., Kinsella T.J. DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO Cells. Clinical Cancer Research 2003, 9:2327-2334.
274. Yin B., Whyatt R.M., Perera F.P., Randall M.C., Cooper T.B., Santella R.M. Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radical Biology and Medicine 1995, 18:1023-1032.
275. Zhang J., Perry G., Smith M.A., Robertson D., Olson S.J., Graham D.G., Montine T.J. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. American Joural of Pathology 1999, 154:1423-1429.